Thiamine-responsive megaloblastic anemia syndrome with novel compound heterozygous SLC19A2 mutations and thrombotic events: a case report

This case broadens the genetic and clinical spectrum of thiamine-responsive megaloblastic anemia, highlighting the importance of genetic testing in young patients with the classic triad and showing that early thiamine therapy can markedly improve outcomes.